| NCT Number | NCT06151600 |
| Lead Sponsor | Elpida Therapeutics SPC |
| Conditions | Peripheral Neuropathy, Neuro-Degenerative Disease, Neuromuscular Diseases |
| Enrollment | 20 participants |
| Start Date | 2024-07-29 |
| Primary Completion | 2031-03-01 (estimated) |
| Study Completion | 2032-03-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-08 |